Ricardo Garvão

Ricardo currently leads efforts to build the corporate capabilities of Biohaven Ireland and the operating plan of the broader Biohaven organization. Ricardo has over 14 years experience in healthcare industries. He joins Biohaven from Canadian biotech Klox Technologies, where he established and led their global animal health business, based out of Ireland, bringing it from technology platform to a market-ready portfolio, successfully licensed globally to a top industry player.

Ricardo was an executive board member in two of the group’s Irish healthcare companies and played a key part developing and optimizing the Irish corporate operations. Earlier in his career, Ricardo held various commercial roles with large pharmaceutical multinationals Novartis and later Zoetis (Pfizer spin out), where he led the marketing and technical function of one of their UK businesses.

Ricardo earned his veterinary medicine degree at Technical University Lisbon and holds a Master of Business Administration from the Warwick Business School.